Weight reduction of at least 5%
Weight reduction of at least 5% has been studied in 1 paper since 2019: 1 trial in people. The newest paper, Oct 12, 2019: “Effect of Weight Reduction on Histological Activity and Fibrosis of Lean Nonalcoholic Steatohepatitis Patient”.
1 paper studies it1 findingUpdated
“In both groups, weight reduction of ≥ 5% was associated with significant reduction in NAS only.”
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave weight reduction of at least 5% to people and measured what changed.
down: Decreases Nonalcoholic Fatty Liver Disease Activity Score
Trial1 year
Weight reduction of 5% or more in lean and non-lean NASH
Journal of translational internal medicine, Oct 12, 2019
What did studies of Weight reduction of at least 5% find?
1Studies of Weight reduction of at least 5% measured 1 outcome; the most studied are Nonalcoholic Fatty Liver Disease Activity Score (1 study).
Nonalcoholic Fatty Liver Disease Activity Score
downin humans1
1 study
Nonalcoholic Fatty Liver Disease Activity Score
downin humans1
Weight reduction of at least 5% decreases Nonalcoholic Fatty Liver Disease Activity Score in humans (weight reduction of 5% or more in lean and non-lean NASH).
“In both groups, weight reduction of ≥ 5% was associated with significant reduction in NAS only.”
Human trialweight reduction of 5% or more in lean and non-lean NASHliver5% or more weight reduction1 year
Journal of translational internal medicine